Skopje, 22 November 2023 (MIA) - The Ministry of Health said Wednesday that an additional Mden 100 million have been approved for the procurement of Trikafta and Kalydeco, the prescription medicine used for the treatment of cystic fibrosis.

The Clinic of Children’s Diseases, the press release reads, received an approval from the Ministry of Health, the Health Insurance Fund and Public Procurement Bureau for immediate procurement though direct negotiations with the authorized distributor of Vertex Pharmaceuticals.

The Clinic for Children's diseases, which is supposed to procure the medicine, said that an agreement was signed between directors of the Clinic and Alkaloid KONS on November 21, and the medicine is supposed to be delivered in the first half of December of this year.

“The current twelve patients, who already receive the medicine, will be receiving 102 therapy regimens for another two months (until April 2024), and the medicine will also be available for additional patients who meet the criteria for Kaftrio in combination with Kalydeco," the Clinic announced.

The Ministry of Health reminds that in 2023, through a conditional budget, the Clinic of Children's Diseases provided and started therapy for 12 patients with cystic fibrosis. Eight of those patients are being monitored in the Clinic, and four of them are monitored at the Clinic of Pulmonology. ssh/sk/

Photo: MIA archive